Buckhorn Inc. v. Orbis Corporation

618 F. App'x 1000
CourtCourt of Appeals for the Federal Circuit
DecidedJuly 2, 2015
Docket2014-1711
StatusUnpublished
Cited by2 cases

This text of 618 F. App'x 1000 (Buckhorn Inc. v. Orbis Corporation) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Buckhorn Inc. v. Orbis Corporation, 618 F. App'x 1000 (Fed. Cir. 2015).

Opinion

DYK, Circuit Judge.

Orbis Corporation and Orbis Material Handling, Inc. (collectively, “Orbis”), the defendant and prevailing party in a patent infringement suit, seeks attorney’s fees against Buckhorn, Inc. (“Buckhorn”), one of the plaintiffs in the infringement action. Buekhorn’s co-plaintiff, Schoeller Area Systems, Inc. (“SAS”), had previously been held liable to Orbis for fees pursuant to an agreement between it (SAS) and Orbis. Orbis argues that it is entitled to recover fees against Buckhorn under an indemnification provision in a patent licensing agreement (the “PLA”) between Buckhorn *1002 and SAS. Orbis also relies on the district court’s inherent power to award attorney’s fees.

The district court awarded fees to Orbis against Buckhorn under the PLA. But Or-bis cannot recover under the PLA because Orbis is neither a party to the PLA nor a third-party beneficiary. Moreover, the district court neither invoked nor had inherent power to award fees in this case. We therefore reverse the district court’s award of fees to Orbis.

BACKGROUND

On December 12, 2008, Buckhorn filed suit against Orbis, alleging infringement of U.S. Patent No. 5,199,592 (“the ’592 patent”), relating to improved hinges on transportation containers. The ’592 patent was not owned by Buckhorn. Rather, SAS owned the patent, and Buckhorn was the (purportedly) co-exclusive licensee of the patent under the PLA. The license granted under the agreement was described as co-exclusive because SAS retained the right to practice the patent as well. 1 The agreement contained an indemnity clause, under which Buckhorn would be obligated to “pay all costs and expenses associated with” SAS’ cooperation if Buckhorn “require[d] [SAS’] cooperation in the maintenance of [an] infringement action.” J.A. 93 § 3.03. Orbis moved to dismiss the complaint brought by Buckhorn on standing grounds; in order to avoid dismissal, SAS joined the suit, and Buckhorn and SAS filed a joint amended complaint.

SAS had previously granted Orbis a license to use the same patent. That license was granted pursuant to a Settlement and License Agreement entered into on September 15, 1992 (“the RX agreement”). Buckhorn was apparently unaware of this license when it commenced the infringement suit against Orbis. 2 The RX agreement contained a fee provision clause:

In any litigation based on a controversy or dispute arising out of or in connection with this Agreement or its interpretation, the prevailing party shall be entitled to recover all fees, costs, reasonable attorneys fees, and other expenses attributable to the litigation.

J.A. 164. Buckhorn was not a party to the RX agreement.

On November 22, 2011, the district court granted summary judgment of non-infringement in favor of Orbis because Orbis was licensed under the RX agreement.

Orbis subsequently requested fees against SAS and Buckhorn. It originally relied on the RX agreement’s fee provision and 35 U.S.C. § 285. The district court denied the fee request. With respect to § 285, the district court declined to award fees because the case was not “exceptional” and “both sides contributed to the dilatory tactics, discovery disputes, and frivolous motions for sanctions.” J.A. 211, 213. With respect to the RX agreement, the district court concluded that the fee provision did not apply because the litigation was not “based on a controversy or dispute arising out of or in connection with the License” and that it would be unconsciona *1003 ble, in light of the amount of time it took Orbis to produce the document, to award fees under it. J.A. 203.

Orbis appealed and challenged only the denial of fees under the RX agreement. Although Orbis listed both SAS and Buck-horn as appellees, Orbis expressly admitted in its briefing before this court: “Buckhorn filed the Initial Complaint, but [it] is not a party to the [RX agreement]. Orbis does not argue in this appeal that Buckhorn is liable under the Fee Provision [of the RX agreement].” Brief for Appellant at 21, Buckhorn Inc. v. Orbis Corp., 547 Fed.Appx. 967 (Fed.Cir. 2013) (No. 2012-1643). We agreed that Buckhorn had no liability under the RX agreement. See Buckhorn, 547 Fed.Appx. at 971 n. 3. We determined that SAS was liable to pay Orbis’ fees under the RX agreement because the language was broad enough to cover infringement disputes arising out of the licensed patents and because an award of fees was not unconscionable. Id. at 971-73. We remanded for the district court to determine a reasonable fee award under that agreement. Id. at 974.

On remand, Buckhorn moved to be dismissed from the case, arguing that the remand proceedings only pertained to the amount of SAS’ liability under the RX agreement. In opposition, Orbis for the first time argued that Buckhorn was liable under the PLA. Although the district court acknowledged that “[t]he only remaining issue being litigated is the request for attorney fees by Defendant Orbis pursuant to the [RX] [a]greement,” J.A. 258, the district court refused to dismiss Buckhorn. It reasoned that Buckhorn was liable to pay SAS’ costs under the PLA, and that “[t]his contractual obligation established Buckhorn’s ongoing significance to this lawsuit.” J.A. 261. Additionally, the court reasoned that the “prosecution of this litigation has been controlled entirely by Buckhorn for its own benefit” and that “leaving] [SAS] to foot the bill” would be “not just.” Id. (citing DirecTV, Inc. v. Leto, 467 F.3d 842, 845 (3d Cir.2006)). Subsequently, the district court awarded Orbis $2,788,594.50 in attorney’s fees. Buckhorn moved for clarification that it was not liable to Orbis under the RX agreement, which it argued was the only basis for Orbis’ fee award. In the district court’s clarification order, the district court acknowledged that “Buckhorn is not liable for attorneys’ fees under the terms of the [RX] [a]greement.” J.A. 43. However, the district court held Buckhorn liable to Orbis under the PLA, even though Orbis was not a party to the PLA, because, according to the district court, “the unambiguous language of the PLA requires Buckhorn to pay any fees that may be ultimately awarded to Orbis.” J.A. 44 (citation and punctuation omitted).

Buckhorn appeals. We have jurisdiction pursuant to 28 U.S.C. § 1295(a)(1). The RX agreement states that it is governed by and construed under California law, and the PLA states that it is governed by and construed under New York law. In such circumstances, California law governs the RX agreement, and New York law governs the PLA. See Power Lift, Inc. v. Weatherford Nipple-Up Sys., Inc., 871 F.2d 1082, 1085 (Fed.Cir.1989); Tele-Save Merch. Co. v. Consumers Distrib. Co.,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kaufman v. Knipp
N.D. Ohio, 2024
Myers Industries, Inc. v. Schoeller Arca Systems, Inc.
171 F. Supp. 3d 107 (S.D. New York, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
618 F. App'x 1000, Counsel Stack Legal Research, https://law.counselstack.com/opinion/buckhorn-inc-v-orbis-corporation-cafc-2015.